Nasdaq Stockholm

Ascelia Pharma AB

ISIN SE0010573113Filings at the FI

At a glance

Most recent filing on September 25, 2026 — an open-market purchase by Andreas Linderoth Norlin on Sep 25, 2026.

We hold 131 visible filings, going back to November 19, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 131 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 131. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Andreas Linderoth Norlin Other senior executive
15,750 SEKOpen-market buy
TradedSep 25, 2026FiledSep 25, 2026
Andreas Linderoth Norlin Other senior executive
20,650 SEKOpen-market buy
TradedSep 25, 2026FiledSep 25, 2026
Magnus Olafsson Corfitzen Chief executive officer
24,975 sharesGrant
TradedNov 25, 2025FiledNov 26, 2025
Andreas Linderoth Norlin Other member of the administrative, management or supervisory body
1,754 sharesGrant
TradedNov 25, 2025FiledNov 26, 2025
Peter Benson Chair of the board
53,400 SEKOpen-market buy
TradedSep 23, 2025FiledSep 23, 2025